Health Insurance to cover three new medications from next month

Published: 2013-06-03 06:59:00

Updated: 2013-06-03 06:59:00

The Ministry of Health and Welfare said Wednesday that national health Insurance will cover Hanmi Pharm’s Pahtension (sildenafil citrate), Otsuka Pharm’s Samsca (tolvaptan) and Takeda Pharm’s Daxas (roflumilast) from June 1.

According to the ministry, the insurance price of Pahtension 20 mg i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK